Learn More
Medchemexpress LLC Epz020411 (hydrochloride) | 2070015-25-5 | 98.15% | 10MM 1ML

Supplier: Medchemexpress LLC HY12970A10MM/1ML
EPZ020411 hydrochloride is a selective inhibitor of PRMT6 with an IC50 of 10 nM. It demonstrates more than 10-fold selectivity for PRMT6 over PRMT1 and PRMT8 and can be used for cancer research.
- Selective inhibitor of PRMT6 (IC50 of 0.01 μM).
- Exhibits over 10-fold selectivity for PRMT6 compared to PRMT1 and PRMT8.
- Decreases H3R2 methylation in A375 cells.
- Reduces neomycin- and cisplatin-induced cell apoptosis and increases hair cell survival.
- Attenuates neomycin- and cisplatin-induced hearing loss in mice.
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.